Latest filing published 05 Jun 2013 for Epizyme, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Amgen Ventures LLC: trading record in brief
Amgen Ventures LLC discloses dealings in Epizyme, Inc. to SEC (Form 4). In total, 2 filings cover trades dated 5 June 2013.
On the market, this insider has only ever bought: 1 purchase, €191k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 5 June 2013, reports a transaction in Epizyme, Inc. The last purchase on record was published on 5 June 2013, which is 4,905 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Amgen Ventures LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 317,460 sharesCommon StockSEC:0001181431-13-032856:0
- 16,666 shares@ US$15.00Common StockSEC:0001181431-13-032856:1Canonical exit: 3 Sept 2013 (T+90)
2 of 2 declarations
